Pharma stock under Rs 50 in focus post this acquisition update – Check details
Stock in focus: On a year-to-date basis, the stock has corrected 27.78 per cent, as compared to a positive return of 3.29 per cent by the benchmark index. Mumbai: Shares of Sudarshan Pharma Industries, a pharmaceutical company, are in focus as the company has shared an update regarding its recent acquisition. According to the information shared with the exchanges, the company has acquired the assets of Telangana-based Srigen Lifesciences Private Limited for Rs 25.50 crore. According to the company, this will lead to an increase in SPIL's manufacturing capacity. Meanwhile, the stock is under Enhanced Surveillance Measure (ESM) Stage 2.…